Speaker Profile
Ph.D., Co-Founder & CEO, Prism AI Tx
Biography
Dr. Zviran is an experienced entrepreneur, scientist, and executive with over 20 years of experience in the defense and life science industries. Dr. Zviran co-founded C2i Genomics, where he served as both CEO and CSO. He guided the company from its beginnings as an academic spin-off to a globally recognized industry leader, culminating in a successful exit. Currently, Dr. Zviran is the co-founder and CEO of Prism AI Therapeutics, an AI-driven multi-omics CDx Dx management company. Additionally, Asaf co-chair the Multi-OmicsAI working group at the BLOODPAC non-profit organization.
Talk
Proven Multi-Modal Biomarkers that Make Drugs Work
Prism AI’s proprietary quantum mechanics-derived AI/ML is uniquely able to transform noisy and high-dimensional multi-omic data into accurate, precise, actionable and mechanistically interpretable biomarkers from as few as 20 patients. Our predictors – of drug efficacy, toxicity, and targets – consistently validate, improving drug development success rates and expanding the patient addressable market.
AI and Data Sciences Showcase:
Prism AI Therapeutics
Prism AI provides a global SaaS platform for the development and commercialization of multi-omic diagnostic (Dx) and companion diagnostic (CDx) assets. Our proprietary quantum mechanics-based AI/ML overcomes the challenges of real-world small-cohort multi-omic data to discover and validate biomarkers that outperform all others. Our services are supported by an extensive network of molecular profiling lab partners.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
